Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001921094-25-000868
Filing Date
2025-08-04
Accepted
2025-08-04 16:09:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3560
  Complete submission text file 0001921094-25-000868.txt   5107
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Subject) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38492 | Film No.: 251180338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KINIKSA PHARMACEUTICALS CORP. 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ragosa Mark (Reporting) CIK: 0001835458 (see all company filings)

Type: 144